{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-014468","form_type":"8-K","ticker":"DNA","cik":"0001830214","company_name":"Ginkgo Bioworks Holdings, Inc.","filed_at":"2022-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.312555+00:00","generated_at":"2026-06-24T04:28:22.805981+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Ginkgo Bioworks appoints Kathy Hopinkah Hannan to its Board of Directors","bullets":["Appointment effective August 2, 2022; term expires at 2023 annual meeting.","Received options to purchase Class A common stock valued at $400,000 plus prorated RSUs and options.","Eligible for $50,000 annual retainer and annual stock awards under Non-Employee Director Compensation Program.","Hannan is retired KPMG Vice Chair and serves on boards of NLY, OTIS, and CRS.","Board determined Dr. Hannan is independent under NYSE listing standards."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-014468","json":"https://secwatch.observer/filing/0000950170-22-014468.json","markdown":"https://secwatch.observer/filing/0000950170-22-014468.md","text":"https://secwatch.observer/filing/0000950170-22-014468.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1830214/000095017022014468/0000950170-22-014468-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1830214/000095017022014468/dna-20220802.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T04:28:22.805981+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2c776ddda1","claim":"Kathy Hopinkah Hannan was appointed as Director at Ginkgo Bioworks Holdings, Inc..","evidence_excerpt":"On August 2, 2022, the Board of Directors (the “Board”) of Ginkgo Bioworks Holdings, Inc. (the “Company”) voted to appoint Kathy Hopinkah Hannan to the Board, effective as of August 2, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1830214/000095017022014468/0000950170-22-014468-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}